Next Pharma

Lonza to Sell two Capsule Sites to NextPharma

Swiss CDMO Lonza said it intends to unload two of its capsule production sites, at Ploermel, France, and Edinburgh, Scotland, for an undisclosed sum to London-based CDMO NextPharma. The proposed deal is subject to regulatory approval. According to reports, most of the affected employees are expected to transfer to the new owner.

Aesica appoints VP, Business Development and Business Development Director for Finished Dose